Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Regulation of p21(WAF1/CIP1) stability by WISp39, a Hsp90 binding TPR protein.

Molecular cell | Jan 21, 2005

p21(WAF1/CIP1), a cyclin-dependent kinase inhibitor and a critical regulator of cell cycle, is controlled transcriptionally by p53-dependent and -independent mechanisms and posttranslationally by the proteasome. We have identified WISp39, a tetratricopeptide repeat (TPR) protein that binds p21. WISp39 stabilizes newly synthesized p21 protein by preventing its proteasomal degradation. WISp39, p21, and hsp90 form a trimeric complex in vivo. The interaction of WISp39 with Hsp90 is abolished by point mutations within the C-terminal TPR domain of WISp39. Although this WISp39 TPR mutant binds p21 in vivo, it fails to stabilize p21. Our results suggest that WISp39 recruits Hsp90 to regulate p21 protein stability. WISp39 downregulation by siRNA prevents the accumulation of p21 and cell cycle arrest after ionizing radiation. The results demonstrate the importance of posttranslational stabilization of p21 protein by WISp39 in regulating cellular p21 activity.

Pubmed ID: 15664193 RIS Download

Mesh terms: Amino Acid Sequence | Animals | Cell Cycle Proteins | Cell Line | Cyclin-Dependent Kinase Inhibitor p21 | Enzyme Inhibitors | HSP90 Heat-Shock Proteins | Humans | Immunophilins | Mice | Molecular Sequence Data | Multiprotein Complexes | Point Mutation | Protein Binding | RNA, Small Interfering | Radiation, Ionizing | Sequence Alignment | Tissue Distribution | Two-Hybrid System Techniques

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: CA10181
  • Agency: NCI NIH HHS, Id: CA92321

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.